Code 99214 reports an established-patient office or outpatient visit at moderate intensity — level 4 of 5. Since the 2021 E/M overhaul, it is earned one of two ways: moderate-complexity medical decision making, or 30–39 minutes of total time on the encounter date. Here is the fact that surprises most clinicians: prescription drug management is moderate-risk by definition — which means a visit managing a worsening chronic condition with a medication change frequently qualifies for 99214, even when it feels routine. That is why E/M distribution reviews so often find money left behind at level 3 (see our 99213 guide for the level below).
Remember the two-of-three rule: a stable-problems visit with moderate data review and prescription management still reaches moderate MDM. The note has to show the ingredients — not just list diagnoses.
| Code | MDM | Total time | Medicare ballpark |
|---|---|---|---|
| 99213 | Low | 20–29 min | ≈ $90 |
| 99214 | Moderate | 30–39 min | ≈ $128 |
| 99215 | High | 40–54 min | ≈ $180 |
Ballparks only — exact allowables move with each year's fee schedule and locality (run yours through the RVU calculator). The ~$38 gap between 99213 and 99214 is the highest-volume revenue decision in outpatient medicine: a clinician seeing 20 patients a day who miscodes just two true level 4s as level 3s leaves roughly $19,000 a year on the table. The reverse error — level 4 claims on level 3 notes — is what payer algorithms screen for, so the goal is accuracy, not ambition.
The same companions as 99213 apply: modifier 25 when a procedure shares the day (expect CO-97 without it), telehealth place-of-service rules (POS 10/POS 02), and diagnosis support — a level 4 claim carried by a single stable-condition ICD-10 invites both CO-50 and prepayment review. Frequency profiling is real: payers compare your 99214 share against specialty norms, and outliers in either direction get letters. The defense is never a target percentage — it is notes that score themselves.
A 58-year-old established patient with diabetes and hypertension comes in for follow-up. The A1c has climbed despite metformin; blood pressure is at goal. The clinician reviews the new lab panel, increases the metformin dose, and adds a second agent. Score it: problems — one chronic illness with progression (moderate) plus one stable chronic illness; data — external lab review (low-to-moderate depending on what else was reviewed); risk — prescription drug management (moderate). Two of three columns at moderate: this is a 99214, and it took no extra documentation beyond an honest note. Now the same patient, both conditions stable, refill unchanged, no labs: problems low, risk arguably moderate, data minimal — one column at moderate is not enough, and the visit is a 99213. The difference was never the length of the note; it was what actually happened clinically, captured precisely.
Related: CPT 99213 guide · Modifier 25 guide · E/M Code Level Calculator · RVU Calculator · CO-97 — bundled service · All CPT guides
Reviewed by Hassan Raza Awan, Founder — 4+ years of hands-on U.S. medical billing experience. General billing information — verify against current CMS guidance and your payer contracts.
We audit E/M levels against documentation and fix both undercoding and exposure. Free one-week billing audit.
Get a Free Billing Audit